Royal Bank Of Canada Cuts Community Health Systems (NYSE:CYH) Price Target to $4.00

Community Health Systems (NYSE:CYH) had its price target reduced by Royal Bank Of Canada from $5.00 to $4.00 in a research note published on Monday,Benzinga reports. They currently have an outperform rating on the stock.

CYH has been the topic of a number of other research reports. Zacks Research lowered shares of Community Health Systems from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 24th. UBS Group lowered their price objective on Community Health Systems from $3.20 to $3.00 and set a “neutral” rating for the company in a report on Friday, July 24th. Wall Street Zen cut Community Health Systems from a “hold” rating to a “sell” rating in a research note on Saturday, July 25th. Weiss Ratings upgraded Community Health Systems from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, July 2nd. Finally, Truist Financial upped their price target on Community Health Systems from $3.00 to $3.75 and gave the company a “hold” rating in a research report on Tuesday, July 14th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $2.95.

Community Health Systems Trading Down 2.2%

Community Health Systems stock opened at $2.73 on Monday. Community Health Systems has a 52 week low of $2.38 and a 52 week high of $4.43. The stock has a market cap of $384.96 million, a P/E ratio of 1.48 and a beta of 1.81. The stock has a 50 day moving average of $3.11 and a 200-day moving average of $3.12.

Community Health Systems (NYSE:CYH) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.09). Community Health Systems had a negative return on equity of 6.66% and a net margin of 2.10%.The company had revenue of $2.83 billion during the quarter, compared to the consensus estimate of $2.89 billion. During the same quarter last year, the firm posted ($0.05) EPS. The firm’s quarterly revenue was down 9.8% on a year-over-year basis. Community Health Systems has set its FY 2026 guidance at -1.250–1.100 EPS. As a group, equities analysts predict that Community Health Systems will post -1.23 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Community Health Systems

Institutional investors have recently made changes to their positions in the stock. Royal Bank of Canada raised its position in shares of Community Health Systems by 601.9% during the 4th quarter. Royal Bank of Canada now owns 9,286 shares of the company’s stock worth $29,000 after purchasing an additional 7,963 shares during the period. Lazard Asset Management LLC acquired a new stake in Community Health Systems in the fourth quarter worth $34,000. Wealthcare Advisory Partners LLC bought a new stake in Community Health Systems in the fourth quarter valued at $35,000. Valeo Financial Advisors LLC acquired a new position in shares of Community Health Systems during the fourth quarter valued at $39,000. Finally, Quarry LP bought a new position in shares of Community Health Systems during the third quarter worth about $39,000. 84.99% of the stock is owned by institutional investors.

About Community Health Systems

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.